- Home
- HUN vs HCM Comparison
HUN vs HCM Comparison
Compare HUN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUN
- HCM
- Stock Information
- Founded
- HUN 1970
- HCM 2000
- Country
- HUN United States
- HCM Hong Kong
- Employees
- HUN N/A
- HCM N/A
- Industry
- HUN Major Chemicals
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- HUN Industrials
- HCM Health Care
- Exchange
- HUN Nasdaq
- HCM Nasdaq
- Market Cap
- HUN 2.4B
- HCM 2.5B
- IPO Year
- HUN 2005
- HCM N/A
- Fundamental
- Price
- HUN $12.05
- HCM $14.21
- Analyst Decision
- HUN Hold
- HCM Hold
- Analyst Count
- HUN 9
- HCM 1
- Target Price
- HUN $15.00
- HCM $19.00
- AVG Volume (30 Days)
- HUN 4.2M
- HCM 82.7K
- Earning Date
- HUN 05-01-2025
- HCM 03-19-2025
- Dividend Yield
- HUN 8.29%
- HCM N/A
- EPS Growth
- HUN N/A
- HCM N/A
- EPS
- HUN N/A
- HCM 0.04
- Revenue
- HUN $5,976,000,000.00
- HCM $630,201,000.00
- Revenue This Year
- HUN $4.09
- HCM $14.86
- Revenue Next Year
- HUN $4.65
- HCM $19.54
- P/E Ratio
- HUN N/A
- HCM $68.70
- Revenue Growth
- HUN 0.02
- HCM N/A
- 52 Week Low
- HUN $11.15
- HCM $11.51
- 52 Week High
- HUN $25.78
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- HUN 38.03
- HCM 45.83
- Support Level
- HUN $11.15
- HCM $14.18
- Resistance Level
- HUN $12.22
- HCM $14.84
- Average True Range (ATR)
- HUN 0.49
- HCM 0.57
- MACD
- HUN -0.02
- HCM -0.03
- Stochastic Oscillator
- HUN 32.19
- HCM 1.94
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. It derives the majority of its revenue from the Polyurethanes segment,t which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.